Default: Molecular Psychiatry

ISSN: 1359-4184

Journal Home

Journal Guideline

Molecular Psychiatry Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Psychiatry is a journal indexed in SJR in Molecular Biology and Cellular and Molecular Neuroscience with an H index of 237. It has a price of 3690 €. It has an SJR impact factor of 3,541 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,541.

Molecular Psychiatry focuses its scope in these topics and keywords: genetic, adult, gene, association, neurogenesis, polymorphism, depressive, candidate, syndrome, brain, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


3690 €

Inmediate OA


Embargoed OA

0 €

Non OA


Molecular Psychiatry


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

genetic, adult, gene, association, neurogenesis, polymorphism, depressive, candidate, syndrome, brain, stress, behavior, receptor, large, major, buffer, responses, variation, anorexia, amyloidosis, altered, alterations,

Best articles by citations

A leadership crisis in American psychiatry

View more

Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers

View more

Inhibition of System A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action

View more

Interleukin-1beta and interleukin-1 receptor antagonist do not affect glutamate release or calcium entry in rat striatal synaptosomes

View more

The phenotypes of bipolar disorder: relevance for genetic investigations

View more

Histochemical localization of Abeta peptide in APP 23 mouse brain

View more

A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease

View more

A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder

View more

Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells express glutamine synthetase: developmental and cell type-specific regulation

View more

Family factors and sampling approach differentially influence attention deficit/hyperactivity disorder subtypes

View more

Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse

View more

The BDNF val66met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples

View more

Baculoviruses expressing the human familial Alzheimer's disease presenilin 1 mutation lacking exon 9 increase levels of an amyloid beta-like protein in Sf9 cells

View more

Schizophrenic women with the APOE e4 allele have a worse prognosis than those without it

View more

Association between Novelty Seeking and the -521 C/T polymorphism in the promoter region of the DRD4 gene

View more

Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia

View more

Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia

View more

Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype

View more

Support for the MnlI polymorphism of SNAP25; a Korean ADHD case-control study

View more

Co-localisation of IgG and complement C1q on the small intestinal epithelium in an autistic child

View more

Excess of allele1 for a3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study

View more

Evidence for the association of the S100beta gene with low cognitive performance and dementia in the elderly

View more

Blockade of CRF1 or V1B receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

View more

A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression

View more